Sort
38,696 grants matching “als”
Neuro-oncology of Familial Neoplasia Syndromes
$646,313Richard Youle · National Institute Of Neurological Disorders And Stroke · ZIA · FY2017 · NS
Substrate recognition and processing by the proteasome
$646,191Daniel J Finley · Harvard Medical School · R01 · FY2019 · GM
Hypothalamus-driven anti-aging processes impact murine models of Alzheimer's Disease
$646,113Tamas L Horvath · Yale University · R01 · FY2021 · AG
Hypothalamus-driven anti-aging processes impact murine models of Alzheimer's Disease
$646,113Tamas L Horvath · Yale University · R01 · FY2022 · AG
Hypothalamus-driven anti-aging processes impact murine models of Alzheimer's Disease
$646,113Tamas L Horvath · Yale University · R01 · FY2024 · AG
Hypothalamus-driven anti-aging processes impact murine models of Alzheimer's Disease
$646,113Tamas L Horvath · Yale University · R01 · FY2023 · AG
Hypothalamus-driven anti-aging processes impact murine models of Alzheimer's Disease
$646,113Tamas L Horvath · Yale University · R01 · FY2020 · AG
Advanced Imaging Core
$646,081Ronald Petralia · National Institute On Deafness And Other Communication Disorders · ZIC · FY2015 · DC
Smoking Cessation Interventions and Program Availability for Drug and Alcohol Add
$646,046Jessica Legge Muilenburg · University Of Georgia · R01 · FY2011 · DA
Phase II trial of tesamorelin for cognition in aging HIV-infected persons
$646,035Ronald J. Ellis · University Of California, San Diego · R01 · FY2019 · AG
Theory-driven treatment of language and cognitive processes in aphasia
$646,013Nadine Martin · Temple Univ Of The Commonwealth · R01 · FY2014 · DC
In Silico Screening of Medications for Slowing Alzheimer's Disease Progression.
$645,978Richard E Kennedy · University Of Alabama At Birmingham · R01 · FY2021 · AG
In Silico Screening of Medications for Slowing Alzheimer's Disease Progression.
$645,978Richard E Kennedy · University Of Alabama At Birmingham · R01 · FY2018 · AG
In Silico Screening of Medications for Slowing Alzheimer's Disease Progression.
$645,978Richard E Kennedy · University Of Alabama At Birmingham · R01 · FY2019 · AG
In Silico Screening of Medications for Slowing Alzheimer's Disease Progression.
$645,978Richard E Kennedy · University Of Alabama At Birmingham · R01 · FY2020 · AG
The relationship between child language proficiency and language of treatment on the outcomes of bilingual children with developmental language disorder
$645,954Anny P. Castilla-Earls · University Of Houston · R01 · FY2023 · DC
Rapid fungal identification and antifungal susceptibility testing through quantitative, multiplexed RNA detection
$645,818Roby Paul Bhattacharyya · Broad Institute, Inc. · R01 · FY2020 · AI
Noise-Induced Synaptic Loss and Vestibular Dysfunction
$645,734William Michael King · University Of Michigan At Ann Arbor · R01 · FY2020 · DC
Epigenetics of Successful Aging
$645,704Eric A Boerwinkle · University Of Texas Hlth Sci Ctr Houston · R01 · FY2018 · HL
Epigenetics of Successful Aging
$645,704Eric A Boerwinkle · University Of Texas Hlth Sci Ctr Houston · R01 · FY2018 · HL
Towards Therapeutics for Neurodegenerative Diseases
$645,645Stanley B Prusiner · University Of California, San Francisco · R37 · FY2017 · AG
Mechanistic Insight to Predict and Prevent Nilotinib-Induced Artery Disease
$645,460Paul W. Burridge · Northwestern University At Chicago · R01 · FY2025 · CA
Effects of Re-expression of Motor Neuron Selector Transcription Factors on ALS Pathology
$645,391Hynek Wichterle · Columbia University Health Sciences · R01 · FY2025 · NS
DNA Methylation at N6-Adenine in Placental Trophoblast Development
$645,331Zongliang Jiang · Louisiana State Univ Agricultural Center · R01 · FY2020 · HD
Corticospinal Neuron Dysfunction and Degeneration in ALS: Testing the Role of Corticomotor Connectivity in Motor Neuron Disease
$645,302Yutaka Yoshida · Winifred Masterson Burke Med Res Inst · R01 · FY2024 · NS